Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis
Clinical trial NCT03086486 · COMPLETED
Trial details
- NCT number
- NCT03086486
- Sponsor
- Global Alliance for TB Drug Development
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-21
- Primary completion
- 2021-02-15
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.